0
0

Department of Health and Human Services Awarded a Contract to GLAXOSMITHKLINE, LLC for $18,161,554.28

Signed on

8/28/2019, 12:00 AM

GLAXOSMITHKLINE, LLC Government Contract #75A50119F33009

GLAXOSMITHKLINE, LLC was awarded a contract with the United States Government for $18,161,554.28. The contract was awarded by the agency office BARDA - ASPR / DAAPPO / BARDA DCMA, which is a division with the Office of Assistant Secretary for Preparedness and Response within the Department of Health and Human Services.

Summary of Award

The recipient of the federal contract is GlaxoSmithKline, LLC, a U.S.-owned business located in Research Triangle Park, North Carolina. The contract, funded by the Department of Health and Human Services, is for a clinical study on H7N9 vaccine with a total value of $18,161,554.28. Notable spending patterns include total obligations of $614,887 and outlays of $11,764,678.21.

Contract Details

Contract ID75A50119F33009
Contract TypeC
Total Obligation$18,161,554.28
Exercised Options$18,161,554.28
Base Amount + Options$18,161,554.28
Date Signed2019-08-28
Contract DescriptionAS03B-H7N9 VACCINE CLINICAL STUDY
Start Date2019-08-28
End Date2024-04-29

Agency Details

Awarding AgencyDepartment of Health and Human Services
Awarding Sub AgencyOffice of Assistant Secretary for Preparedness and Response
Awarding OfficeBARDA - ASPR / DAAPPO / BARDA DCMA
Funding AgencyDepartment of Health and Human Services
Funding Sub AgencyOffice of Assistant Secretary for Preparedness and Response
Funding OfficeBARDA - ASPR / DAAPPO / BARDA DCMA

Recipient Details

RecipientGLAXOSMITHKLINE, LLC
Recipient Location5 MOORE DR RESEARCH TRIANGLE PARK NORTH CAROLINA, UNITED STATES
Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Limited Liability Corporation, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions